News Home

Is Applied Molecular Transport Inc. (AMTI) Stock About to Get Hot Friday?

Friday, August 05, 2022 12:30 PM | InvestorsObserver Analysts
Is Applied Molecular Transport Inc. (AMTI) Stock About to Get Hot Friday?

Overall market sentiment has been high on Applied Molecular Transport Inc. (AMTI) stock lately. AMTI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Applied Molecular Transport Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AMTI!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With AMTI Stock Today?

Applied Molecular Transport Inc. (AMTI) stock is trading at $2.02 as of 12:28 PM on Friday, Aug 5, a rise of $0.09, or 4.4% from the previous closing price of $1.93. The stock has traded between $1.83 and $2.07 so far today. Volume today is low. So far 95,796 shares have traded compared to average volume of 643,167 shares.

More About Applied Molecular Transport Inc.

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue. Click Here to get the full Stock Report for Applied Molecular Transport Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App